Clinical Cancer Prevention

Editors:

ISBN: 978-3-642-10856-3 (Print) 978-3-642-10858-7 (Online)

Table of contents (13 chapters)

  1. Front Matter

    Pages i-x

  2. No Access

    Book Chapter

    Pages 1-9

    Allocating Cancer-Directed Expenditures: Tensions Between Prevention, Early Detection and Treatment is Unnecessary

  3. No Access

    Book Chapter

    Pages 11-20

    Lessons Learned from Prevention Programs: Different Endpoints Should Be Used in Secondary and Tertiary Prevention

  4. No Access

    Book Chapter

    Pages 21-47

    Biomarkers for Early Detection and as Surrogate Endpoints in Cancer Prevention Trials: Issues and Opportunities

  5. No Access

    Book Chapter

    Pages 49-64

    Targeting Polyamines and Inflammation for Cancer Prevention

  6. No Access

    Book Chapter

    Pages 65-74

    Thinking About the Role (Largely Ignored) of Heavy Metals in Cancer Prevention: Hexavalent Chromium and Melanoma as a Case in Point

  7. No Access

    Book Chapter

    Pages 75-84

    Hepatitis B Virus and Cancer Prevention

  8. No Access

    Book Chapter

    Pages 85-99

    Chemoprevention of Hepatocellular Carcinoma in Chronic Hepatitis C

  9. No Access

    Book Chapter

    Pages 101-107

    Nutritional Aspects of Primary Prostate Cancer Prevention

  10. No Access

    Book Chapter

    Pages 109-114

    Prostate Cancer Prevention with 5 Alpha-Reductase Inhibitors

  11. No Access

    Book Chapter

    Pages 115-124

    Hormone Replacement Therapy and Breast Cancer

  12. No Access

    Book Chapter

    Pages 125-139

    Physical Activity and Breast Cancer: Review of the Epidemiologic Evidence and Biologic Mechanisms

  13. No Access

    Book Chapter

    Pages 141-145

    Prevention of Breast Cancer by Newer SERMs in the Future

  14. No Access

    Book Chapter

    Pages 147-162

    Chemoprevention of Hormone Receptor-Negative Breast Cancer: New Approaches Needed